Doctors diagnose Alzheimer's disease through a combined clinical evaluation, not one definitive test. They assess symptoms and daily function, test thinking skills, rule out other causes, and sometimes use brain scans or biomarkers before making specialist referrals. A biomarker is a measurable biological sign of disease, such as certain proteins found in blood or spinal fluid. Biomarkers can strengthen or weaken the case for Alzheimer's, but doctors must interpret them alongside the person's symptoms and examination.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What happens during the initial evaluation?
- What do cognitive tests reveal?
- How do doctors rule out other causes?
- When is a specialist referral useful?
- What can biomarker tests add?
- How should someone prepare for an appointment?
What happens during the initial evaluation?
The clinician asks the patient about changes in memory, attention, language, problem-solving, mood, and behavior. They also review medicines and determine whether cognitive problems interfere with routine tasks, such as managing appointments or following familiar activities.
Someone who knows the patient well may provide additional observations. According to the National Institute on Aging's diagnostic overview, this history, functional review, and cognitive testing work together; no single result establishes the diagnosis.
What do cognitive tests reveal?
Brief screening tests check areas such as memory, attention, language, and problem-solving. They can show whether a person needs further assessment, but they cannot identify the cause of the difficulty by themselves. A positive screen does not automatically mean dementia or Alzheimer's disease.
The National Institute on Aging's guidance for clinicians says an abnormal result should lead to a fuller evaluation, which may include neuropsychological testing and information from someone close to the patient. Neuropsychological assessment examines thinking abilities in greater detail. Its results help clinicians describe the pattern and severity of impairment, while the broader evaluation determines what may be causing it.
How do doctors rule out other causes?
Doctors commonly order blood, urine, or other medical tests to look for explanations besides Alzheimer's. They review possible medication effects and consider infection, depression, stroke, tumors, sleep disorders, and other dementias. Some alternative causes may be treatable or reversible.
A psychiatric assessment may be appropriate when mood or behavior could explain or complicate the symptoms. Finding depression, for example, does not by itself settle whether another cognitive disorder is also present. CT or MRI scans can show bleeding, strokes, tumors, fluid buildup, and other structural problems. MRI-visible brain shrinkage may support clinical concerns, but it cannot establish that Alzheimer's is the specific cause.
When is a specialist referral useful?
A primary-care clinician may refer the patient to a geriatrician, neurologist, geriatric psychiatrist, neuropsychologist, or multidisciplinary memory clinic. Referral is especially useful when the diagnosis remains uncertain or detailed cognitive assessment and advanced testing may affect decisions. A memory clinic can bring several kinds of expertise into one evaluation.
Depending on the case, specialists may arrange advanced scans, cerebrospinal fluid testing, or other assessments unavailable during a routine primary-care visit. Specialist involvement does not replace the initial history and functional review. Advanced results still need to be interpreted in the context of the patient's symptoms, cognitive testing, medicines, and daily abilities.
What can biomarker tests add?
Amyloid PET scans show the burden of beta-amyloid plaques in the brain. Few or no plaques usually argue against Alzheimer's as the cause of symptoms. A positive result is not conclusive because some people have amyloid plaques without developing Alzheimer's symptoms.
Doctors may also use a lumbar puncture to collect cerebrospinal fluid and measure beta-amyloid 42, tau, and phospho-tau. The National Institute on Aging's biomarker guidance emphasizes that imaging, fluid markers, and clinical findings serve different purposes and must be considered together. Blood biomarkers may help triage patients for additional testing or confirm Alzheimer's-related pathology when the test performs well. However, the Alzheimer's Association's 2025 specialty-care guideline applies these tests after objective cognitive impairment and a comprehensive clinical evaluation; many marketed tests do not meet its accuracy thresholds.
How should someone prepare for an appointment?
Useful preparation focuses on evidence the clinician needs: Genetic testing is not routinely used to diagnose or predict Alzheimer's. A neurologist or another specialist may consider it when cognitive symptoms begin early and there is a strong family history, typically with genetic counseling before or alongside testing.
- Bring a complete list of prescription medicines, over-the-counter products, and supplements.
- Write down specific cognitive or behavioral changes and when they became noticeable.
- Note which daily activities have become harder or require help.
- Ask a trusted person who knows the patient well to attend or provide observations.
- Bring previous cognitive-test, laboratory, or brain-scan results if available.
